SCHEMBL8253497

SCHEMBL8253497

COC(=O)[C@@H]1CC=CCOc2ccc(cc2)C[C@@H](NC(C)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ F2 P00734 8/20 0.47
▸ TMPRSS2 O15393 7/20 0.47
▸ HPN P05981 7/20 0.47
▸ ST14 Q9Y5Y6 7/20 0.47
▸ HGFAC Q04756 5/20 0.47
▸ HDAC3 O15379 1/20 0.47
▸ HDAC4 P56524 1/20 0.47
▸ HDAC1 Q13547 1/20 0.47
▸ HDAC7 Q8WUI4 1/20 0.47
▸ HDAC2 Q92769 1/20 0.47
▸ HDAC10 Q969S8 1/20 0.47
▸ HDAC11 Q96DB2 1/20 0.47
▸ HDAC8 Q9BY41 1/20 0.47
▸ HDAC6 Q9UBN7 1/20 0.47
▸ HDAC9 Q9UKV0 1/20 0.47
▸ HDAC5 Q9UQL6 1/20 0.47
▸ F10 P00742 3/20 0.43
▸ OPRM1 P35372 5/20 0.42
▸ OPRK1 P41145 5/20 0.42
▸ PLG P00747 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8257555 1.00 F2 (0.47) F2TMPRSS2HPNST14HGFAC
SCHEMBL8257829 1.00 F2 (0.47) F2TMPRSS2HPNST14HGFAC
SCHEMBL8260491 1.00 F2 (0.47) F2TMPRSS2HPNST14HGFAC
SCHEMBL12214881 1.00 F2 (0.47) F2TMPRSS2HPNST14HGFAC
SCHEMBL12214923 0.98 HDAC3 (0.48) F2TMPRSS2HPNST14HGFAC
SCHEMBL14597656 0.89 HDAC3 (0.51) F2TMPRSS2HPNST14HGFAC
SCHEMBL12214853 0.88 HDAC3 (0.52) F2TMPRSS2HPNST14HGFAC
SCHEMBL14847433 0.88 HDAC3 (0.52) F2TMPRSS2HPNST14HGFAC
SCHEMBL12214828 0.88 HDAC3 (0.52) F2TMPRSS2HPNST14HGFAC
Hydrochloric Acid SCHEMBL2358557 0.88 HDAC3 (0.51) F2TMPRSS2HPNST14HGFAC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8524657-B2 Peptidic compounds UNIVERSITY OF WOLLONGONG (AU) 2013-09-03 — — US disclosed
EP-1836159-B1 Antibiotic binaphthyl derivatives UNIV WOLLONGONG (AU) 2013-04-10 — — EP disclosed
US-20110312875-A1 PEPTIDIC COMPOUNDS UNIVERSITY OF WOLLONGONG (AU) 2011-12-22 — — US disclosed
US-8039430-B2 Peptidic compounds UNIVERSITY OF WOLLONGONG (AU) 2011-10-18 — — US disclosed
US-8039430-B2 Peptidic compounds UNIVERSITY OF WOLLONGONG (AU) 2011-10-18 — — US disclosed
EP-2199300-A2 Peptidic compounds The University Of Wollongong (AU) 2010-06-23 — — EP disclosed
US-20080300287-A1 Peptidic Compounds UNIVERSITY OF WOLLONGONG (AU) 2008-12-04 — — US disclosed
US-20080300287-A1 Peptidic Compounds UNIVERSITY OF WOLLONGONG (AU) 2008-12-04 — — US disclosed
WO-2006074501-A1 PEPTIDIC COMPOUNDS UNIVERSITY OF WOLLONGONG (AU) 2006-07-20 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080300287-A1 Peptidic Compounds VIP, NGLY1, FURIN F2 1125/4885TMPRSS2 405/4885HPN 289/4885
US-20110312875-A1 PEPTIDIC COMPOUNDS VIP, NGLY1, FURIN F2 911/4885TMPRSS2 327/4885HPN 285/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback